An interventional study of Wakeful Digital Mindfulness Program in Program Engagement, Treatment Adherence and Compliance and Mindfulness, sponsored by Northwestern University. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-05-26.
Sponsored by Northwestern University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Treatment Adherence and Compliance with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Treatment Adherence and Compliance · United States.
Among the 75 studies in Treatment Adherence and Compliance with a site in United States, this one is the 46th largest by planned enrollment of the 70 interventional ones that give a count, is one of 5 that started in 2026, is one of 58 with no phase, reaches primary completion later than 3 of the 14 other live ones, and was the 70th registered.
353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.
Browse Treatment Adherence and Compliance studies →12 of the 75 studies in Treatment Adherence and Compliance with a site in United States are open now. Recruiting first, the newest first:
Virginia Commonwealth University · Sites in United States
Ages 18+
University of Maryland, Baltimore · Sites in United States
Ages 18–65
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18+ · Women only
National Heart, Lung, and Blood Institute (NHLBI) · Sites in United States
Ages 18+
Lifespan · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 8 · Phase 3 4 · Phase 4 1
First in 2003; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 42 is below the median of 83 across 273 interventional studies indexed under Treatment Adherence and Compliance.
Median enrollment 66 across the 70 interventional studies, 384 across the 5 observational. Of the 57 that completed or were terminated, 23 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 75 have an industry lead sponsor. The 10 most frequent:
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
Northwestern University has 1 study filed under Treatment Adherence and Compliance — fewer than ten, so there is no comparison to draw.
7 of the studies in Treatment Adherence and Compliance with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05489068University of New MexicoMotivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment | 2026-12-01 |
| NCT07542769Northwestern UniversityChoice and Autonomy in Learning Mindfulness for Pediatric Residents | 2026-12-31 |
| NCT07881783Novartis PharmaceuticalsA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy | 2027-03-31 |
| NCT05973838University of Maryland, College ParkPeer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention | 2027-07-01 |
| NCT06909552University of Colorado, DenverUse of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction | 2027-07-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 75 studies in Treatment Adherence and Compliance with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a pilot clinical trial designed to evaluate a flexible, online mindfulness program for pediatric residents. Medical training can be stressful, and although mindfulness programs are often offered to support well-being, many are either in-person or follow a fixed format that may not fit individual schedules or preferences. This study will test a digital mindfulness program called Wakeful, which allows participants to complete the course at their own pace. Participants will be randomly assigned to one of two groups: one group will be able to choose the length of their mindfulness program (3, 5, or 7 weeks), while the other group will be assigned a program length without a choice. The goal is to understand whether giving participants a choice improves how often they use the program, how satisfied they are with it, and whether they complete it. The main outcomes of this study focus on how participants interact with the program, including how many sessions they complete, how often they practice mindfulness on their own, and how useful and relevant they find the program. The study will also look at overall satisfaction and how many participants drop out before finishing. In addition, the study will explore whether participants report changes in mindfulness and compassion for others, although it is not designed to determine clinical improvements in mental health. By understanding how pediatric residents engage with different program formats, this study aims to inform the design of more flexible and user-centered digital wellness programs that better fit into demanding medical training environments.
This pilot randomized study evaluates the feasibility, acceptability, and user engagement of a digital, asynchronous mindfulness-based intervention (Wakeful) among pediatric residents. The study is designed to address a key limitation in existing mindfulness interventions: the predominance of "one-size-fits-all" program structures that may not align with the time constraints, preferences, and autonomy of medical trainees.
Background and Rationale
Pediatric residents experience significant occupational stress due to demanding clinical schedules, high patient volumes, and emotionally complex care environments. Although mindfulness-based interventions, including those derived from Mindfulness-Based Stress Reduction (MBSR), have demonstrated potential benefits, traditional in-person formats are often impractical for trainees. Digital mindfulness programs offer increased accessibility; however, engagement and adherence remain suboptimal.
A potential contributor to low engagement is the lack of personalization in program design. Most digital interventions prescribe a fixed duration and structure, without accounting for individual differences in time availability, motivation, or perceived burden. Allowing participants to choose key aspects of the intervention-such as program length-may enhance perceived autonomy and improve engagement and acceptability.
Study Objectives
The primary objective of this study is to evaluate whether offering participants a choice of intervention duration (3, 5, or 7 weeks) influences engagement, adherence, and acceptability of a digital mindfulness program.
Secondary exploratory objectives include assessing trends in self-reported mindfulness and compassion for others following participation in the program.
Study Design
This is a randomized, parallel-group pilot study conducted among pediatric residents at a single academic institution. Approximately 42 participants will be enrolled and randomized in a 1:1 ratio to one of two study arms:
Choice Arm (n = 21): Participants select their preferred program duration (3, 5, or 7 weeks).
No-Choice Arm (n = 21): Participants are assigned a program duration without input, using a matched randomization approach to ensure balanced distribution across durations.
Participants in both arms will complete one Wakeful session per week based on their assigned or selected schedule. Each session lasts approximately 45-60 minutes and includes didactic content, guided meditation, and optional reflective exercises.
Intervention
Wakeful is a web-based mindfulness program developed at Northwestern University. It delivers structured weekly content incorporating mindfulness principles, including attention awareness, emotional regulation, and loving-kindness practices. The platform includes guided meditations, educational materials, and optional community reflection features.
Participants may also engage in optional independent mindfulness practices outside of the structured sessions. All engagement occurs remotely, and participants may access the program via computer, tablet, or smartphone.
Data Collection and Outcome Measures Primary Outcomes (Engagement and Acceptability)
Primary outcomes focus on user interaction with the intervention and include:
Module completion rates Frequency and duration of platform use Independent meditation practice frequency Participant-reported usability and perceived relevance Satisfaction with the program Attrition and dropout rates
These measures will be derived from de-identified platform usage data and participant surveys.
Secondary (Exploratory) Outcomes
Exploratory outcomes include changes in:
Mindfulness (PROMIS Global Mindfulness Measure) Compassion for others (Neff Compassion Scale)
The study is not powered to detect statistically significant differences in psychological outcomes; these analyses are descriptive and hypothesis-generating.
Procedures
After providing informed consent, participants will be randomized to study arm. Those in the Choice Arm will select their preferred program duration, while those in the No-Choice Arm will be assigned a duration.
Participants will complete:
A baseline questionnaire prior to beginning the intervention A post-intervention questionnaire at program completion An optional in-person debrief interview 2-4 weeks after completion (subset of participants)
The debrief interviews will explore participant experiences, including factors influencing their engagement and perceptions of program structure.
Data Handling
All usage data collected by the Wakeful platform will be de-identified and linked only to a study ID. No personally identifiable information will be included in analytic datasets. Data will be stored on secure, encrypted servers, and only authorized study personnel will have access.
Significance
This study focuses on feasibility and user experience rather than clinical efficacy. By evaluating whether participant choice influences engagement, the findings will inform the design of future digital mindfulness interventions that prioritize flexibility, personalization, and alignment with the realities of medical training environments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- None; all pediatric residents meeting inclusion criteria are eligible.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants randomized to the Choice arm will select their preferred duration of the Wakeful digital mindfulness program (3, 5, or 7 weeks) prior to beginning the intervention. After making their selection, participants will complete one module per week in sequential order based on their chosen program length. Each module includes didactic content, guided mindfulness practices, and optional reflection activities. Participants may also engage in optional independent meditation practices throughout the study period. This arm is designed to evaluate whether allowing participants to choose their intervention duration influences engagement, adherence, and acceptability of the program.
Behavioral: Wakeful Digital Mindfulness Program
Participants randomized to the No-Choice arm are assigned a Wakeful digital mindfulness program duration (3, 5, or 7 weeks) without input. Assignment is matched to participants in the Choice arm to balance program lengths across groups. Participants complete one module per week in sequential order according to their assigned program length. Each module includes didactic content, guided mindfulness practices, and optional reflection activities. Optional independent meditation practice is also available. This arm is designed to assess engagement, adherence, and acceptability under a structured format without participant-selected program duration.
Behavioral: Wakeful Digital Mindfulness Program
Wakeful digital mindfulness program: an asynchronous, web-based course with guided meditations, didactic content, and optional reflective exercises.
Engagement and completion of Wakeful program modules
The primary outcome measures participant engagement with the Wakeful digital mindfulness program, including (1) the number of program modules completed, (2) frequency and duration of platform use, (3) frequency of independent meditation practice, (4) perceived usability and relevance, and (5) overall satisfaction and dropout rates. All measures are collected via de-identified platform usage data and post-intervention surveys to assess acceptability and adherence.
Time frame: Baseline and immediately post-intervention (3, 5, or 7 weeks depending on program length)
Changes in mindfulness, self-compassion, and compassion for others
Exploratory outcomes assess trends in psychological constructs following the Wakeful digital mindfulness program. Measures include mindfulness using the PROMIS Global Mindfulness Measure, self-compassion using the Neff Self-Compassion Scale, and compassion for others using the Neff Compassion Scale. These surveys are completed at baseline and post-intervention. The study is not powered for statistical comparisons; analyses are descriptive to guide future intervention design.
Time frame: Baseline and immediately post-intervention (3, 5, or 7 weeks depending on program length)
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.
Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's planned 8 months is below that.
Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Treatment Adherence and Compliance →